Latest Articles

Publication Date
Deciphering the Role of ZEB1 as a Central Regulator of Epithelial-Mesenchymal Transition and Hormonal Resistance in Endometriosis.

Endometriosis is a chronic inflammatory and sex steroid hormone-dependent gynaecologic disease, characterised by endometrial cell proliferation outside the uterine cavity, often accompanied by fibrosis, progesterone resistance, and high recurrence despite …

Published: Sept. 9, 2026, midnight
GREB1 as a Context-Dependent Molecular Switch in Endometrial Estrogen-Progesterone Crosstalk: From Physiological Receptivity to Endometriosis Pathogenesis-A Narrative Review.

In this narrative review, we summarize current evidence regarding the endometrium undergoes cyclic remodeling driven by estrogen (E2) and progesterone (P4) signaling, with precise coordination essential for receptivity and pregnancy …

Published: Sept. 9, 2026, midnight
State of the art imaging for endometriosis and adenomyosis.

Endometriosis is a chronic oestrogen-dependent condition characterised by the presence of endometrial-like tissue outside the uterus. Although benign, the associated chronic inflammation and fibrosis can result in substantial symptomatic burden, …

Published: Sept. 9, 2026, midnight
Lipid-lowering agents linked to improved survival in women with endometrial Ca - Contemporary OB/GYN

Lipid-lowering agents linked to improved survival in women with endometrial Ca Contemporary OB/GYN

Published: Sept. 8, 2026, 8 p.m.
Doctoral student earns NIH award to investigate endometrial cancer vulnerabilities - Today@Wayne

Doctoral student earns NIH award to investigate endometrial cancer vulnerabilities Today@Wayne

Published: Sept. 8, 2026, 3:25 p.m.
Doctoral student earns NIH award to investigate endometrial cancer vulnerabilities - today.wayne.edu

Doctoral student earns NIH award to investigate endometrial cancer vulnerabilities today.wayne.edu

Published: Sept. 8, 2026, 3:25 p.m.
Faeth Therapeutics to Host Virtual KOL Event on Multi-Nodal Inhibition for the Treatment of Endometrial Cancer on October 6, 2026 - Business Wire

Faeth Therapeutics to Host Virtual KOL Event on Multi-Nodal Inhibition for the Treatment of Endometrial Cancer on October 6, 2026 Business Wire

Published: Sept. 8, 2026, 11:30 a.m.
Faeth Therapeutics to Host Virtual KOL Event on Multi-Nodal Inhibition for the Treatment of Endometrial Cancer on October 6, 2026 - businesswire.com

Faeth Therapeutics to Host Virtual KOL Event on Multi-Nodal Inhibition for the Treatment of Endometrial Cancer on October 6, 2026 businesswire.com

Published: Sept. 8, 2026, 11:30 a.m.
The hidden impacts of endocrine-disrupting chemicals on endometrial and pregnancy health.

Endocrine-disrupting chemicals (EDCs) are ubiquitous environmental contaminants that interfere with hormone signalling and are increasingly linked to adverse reproductive outcomes. This viewpoint highlights emerging evidence that EDC exposure disrupts both …

Published: Sept. 8, 2026, midnight
Ectopic Endometrium-Targeted M1 Macrophage-Derived Nanovesicles for Treatment of Endometriosis.

Endometriosis (EMs) is a common gynecological disorder in women of reproductive age, often presenting with pelvic pain and infertility. Its progression is closely linked to estrogen levels. While hormonal therapies …

Published: Sept. 8, 2026, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!